Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension

BackgroundOptions for interventional therapy to lower blood pressure (BP) in patients with treatment‐resistant hypertension include renal denervation and the creation of an arteriovenous anastomosis using the ROX coupler. It has been shown that BP response after renal denervation is greater in patie...

Full description

Bibliographic Details
Main Authors: Christian Ott, Melvin D. Lobo, Paul A. Sobotka, Felix Mahfoud, Alice Stanton, John Cockcroft, Neil Sulke, Eamon Dolan, Markus van der Giet, Joachim Hoyer, Stephen S. Furniss, John P. Foran, Adam Witkowski, Andrzej Januszewicz, Danny Schoors, Konstantinos Tsioufis, Benno J. Rensing, Manish Saxena, Benjamin Scott, G. André Ng, Stephan Achenbach, Roland E. Schmieder, Michael Schmid, Ajay Jain, Charles Knight, Anthony Mathur, Peter Balmforth, Sandra F. Luitjens, Gerard Smits, Dhanraj Mungur, Aleksander Prejbisz, Jacek Kadziela, Elżbieta Florczak, Joseph Galvin, Kyriakos Dimitriadis
Format: Article
Language:English
Published: Wiley 2016-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004234
_version_ 1818315187705348096
author Christian Ott
Melvin D. Lobo
Paul A. Sobotka
Felix Mahfoud
Alice Stanton
John Cockcroft
Neil Sulke
Eamon Dolan
Markus van der Giet
Joachim Hoyer
Stephen S. Furniss
John P. Foran
Adam Witkowski
Andrzej Januszewicz
Danny Schoors
Konstantinos Tsioufis
Benno J. Rensing
Manish Saxena
Benjamin Scott
G. André Ng
Stephan Achenbach
Roland E. Schmieder
Michael Schmid
Ajay Jain
Charles Knight
Anthony Mathur
Peter Balmforth
Sandra F. Luitjens
Gerard Smits
Dhanraj Mungur
Aleksander Prejbisz
Jacek Kadziela
Elżbieta Florczak
Joseph Galvin
Kyriakos Dimitriadis
author_facet Christian Ott
Melvin D. Lobo
Paul A. Sobotka
Felix Mahfoud
Alice Stanton
John Cockcroft
Neil Sulke
Eamon Dolan
Markus van der Giet
Joachim Hoyer
Stephen S. Furniss
John P. Foran
Adam Witkowski
Andrzej Januszewicz
Danny Schoors
Konstantinos Tsioufis
Benno J. Rensing
Manish Saxena
Benjamin Scott
G. André Ng
Stephan Achenbach
Roland E. Schmieder
Michael Schmid
Ajay Jain
Charles Knight
Anthony Mathur
Peter Balmforth
Sandra F. Luitjens
Gerard Smits
Dhanraj Mungur
Aleksander Prejbisz
Jacek Kadziela
Elżbieta Florczak
Joseph Galvin
Kyriakos Dimitriadis
author_sort Christian Ott
collection DOAJ
description BackgroundOptions for interventional therapy to lower blood pressure (BP) in patients with treatment‐resistant hypertension include renal denervation and the creation of an arteriovenous anastomosis using the ROX coupler. It has been shown that BP response after renal denervation is greater in patients with combined hypertension (CH) than in patients with isolated systolic hypertension (ISH). We analyzed the effect of ROX coupler implantation in patients with CH as compared with ISH. Methods and ResultsThe randomized, controlled, prospective ROX Control Hypertension Study included patients with true treatment‐resistant hypertension (office systolic BP ≥140 mm Hg, average daytime ambulatory BP ≥135/85 mm Hg, and treatment with ≥3 antihypertensive drugs including a diuretic). In a post hoc analysis, we stratified patients with CH (n=31) and ISH (n=11). Baseline office systolic BP (177±18 mm Hg versus 169±17 mm Hg, P=0.163) and 24‐hour ambulatory systolic BP (159±16 mm Hg versus 154±11 mm Hg, P=0.463) did not differ between patients with CH and those with ISH. ROX coupler implementation resulted in a significant reduction in office systolic BP (CH: −29±21 mm Hg versus ISH: −22±31 mm Hg, P=0.445) and 24‐hour ambulatory systolic BP (CH: −14±20 mm Hg versus ISH: −13±15 mm Hg, P=0.672), without significant differences between the two groups. The responder rate (office systolic BP reduction ≥10 mm Hg) after 6 months was not different (CH: 81% versus ISH: 82%, P=0.932). ConclusionsOur data suggest that creation of an arteriovenous anastomosis using the ROX coupler system leads to a similar reduction of office and 24‐hour ambulatory systolic BP in patients with combined and isolated systolic hypertension. Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01642498.
first_indexed 2024-12-13T09:01:33Z
format Article
id doaj.art-32ddedfb0ddf411eb67ff3e3f09c5c67
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-13T09:01:33Z
publishDate 2016-12-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-32ddedfb0ddf411eb67ff3e3f09c5c672022-12-21T23:53:09ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802016-12-0151210.1161/JAHA.116.004234Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined HypertensionChristian Ott0Melvin D. Lobo1Paul A. Sobotka2Felix Mahfoud3Alice Stanton4John Cockcroft5Neil Sulke6Eamon Dolan7Markus van der Giet8Joachim Hoyer9Stephen S. Furniss10John P. Foran11Adam Witkowski12Andrzej Januszewicz13Danny Schoors14Konstantinos Tsioufis15Benno J. Rensing16Manish Saxena17Benjamin Scott18G. André Ng19Stephan Achenbach20Roland E. Schmieder21Michael SchmidAjay JainCharles KnightAnthony MathurPeter BalmforthSandra F. LuitjensGerard SmitsDhanraj MungurAleksander PrejbiszJacek KadzielaElżbieta FlorczakJoseph GalvinKyriakos DimitriadisDepartment of Nephrology and Hypertension, Friedrich‐Alexander University Erlangen‐Nürnberg (FAU), Erlangen, GermanyWilliam Harvey Research Institute, Barts NIHR Cardiovascular Biomedical Research Unit, Queen Mary University of London, United KingdomROX Medical, San Clemente, CAKlinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyMolecular and Cellular Therapeutics, Royal College of Surgeons in Ireland Medical School, Dublin, IrelandCardiolgy Department, Wales Heart Research Institute, Cardiff, United KingdomCardiology Department, Eastbourne District General Hospital, East Sussex, United KingdomDepartment of Medicine for the Elderly, Connolly Hospital, Dublin, IrelandDepartment of Endocrinology and Nephrology, Universitätsmedizin Berlin, Berlin, GermanyDepartment of Internal Medicine and Nephrology, Universitätsklinikum Gießen und Marburg GmbH, Marburg, GermanyDepartment of Cardiology, East Sussex Healthcare NHS Trust, East Sussex, United KingdomCardiac Department, Royal Brompton Hospital, London, United KingdomInstitute of Cardiology, Warsaw, PolandInstitute of Cardiology, Warsaw, PolandDepartment of Cardiology, Universitair Ziekenhuis Brussel, Brussels, BelgiumDepartment of Cardiology, Hippokration General Hospital of Athens, GreeceDepartment of Cardiology, St. Antonius Ziekenhuis, Nieuwegein, the NetherlandsWilliam Harvey Research Institute, Barts NIHR Cardiovascular Biomedical Research Unit, Queen Mary University of London, United KingdomDepartment of Cardiology, ZNA ‐ Cardio Middelheim, Antwerp, BelgiumDepartment of Cardiovascular Sciences, University of Leicester Glenfield Hospital/NIHR Leicester Cardiovascular Biomedical Research, Leicester, United KingdomDepartment of Cardiology, Friedrich‐Alexander University Erlangen‐Nürnberg (FAU), Erlangen, GermanyDepartment of Nephrology and Hypertension, Friedrich‐Alexander University Erlangen‐Nürnberg (FAU), Erlangen, GermanyBackgroundOptions for interventional therapy to lower blood pressure (BP) in patients with treatment‐resistant hypertension include renal denervation and the creation of an arteriovenous anastomosis using the ROX coupler. It has been shown that BP response after renal denervation is greater in patients with combined hypertension (CH) than in patients with isolated systolic hypertension (ISH). We analyzed the effect of ROX coupler implantation in patients with CH as compared with ISH. Methods and ResultsThe randomized, controlled, prospective ROX Control Hypertension Study included patients with true treatment‐resistant hypertension (office systolic BP ≥140 mm Hg, average daytime ambulatory BP ≥135/85 mm Hg, and treatment with ≥3 antihypertensive drugs including a diuretic). In a post hoc analysis, we stratified patients with CH (n=31) and ISH (n=11). Baseline office systolic BP (177±18 mm Hg versus 169±17 mm Hg, P=0.163) and 24‐hour ambulatory systolic BP (159±16 mm Hg versus 154±11 mm Hg, P=0.463) did not differ between patients with CH and those with ISH. ROX coupler implementation resulted in a significant reduction in office systolic BP (CH: −29±21 mm Hg versus ISH: −22±31 mm Hg, P=0.445) and 24‐hour ambulatory systolic BP (CH: −14±20 mm Hg versus ISH: −13±15 mm Hg, P=0.672), without significant differences between the two groups. The responder rate (office systolic BP reduction ≥10 mm Hg) after 6 months was not different (CH: 81% versus ISH: 82%, P=0.932). ConclusionsOur data suggest that creation of an arteriovenous anastomosis using the ROX coupler system leads to a similar reduction of office and 24‐hour ambulatory systolic BP in patients with combined and isolated systolic hypertension. Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01642498.https://www.ahajournals.org/doi/10.1161/JAHA.116.004234arteriovenous anastomosiscombined hypertensionisolated systolic hypertensiontreatment resistant hypertension
spellingShingle Christian Ott
Melvin D. Lobo
Paul A. Sobotka
Felix Mahfoud
Alice Stanton
John Cockcroft
Neil Sulke
Eamon Dolan
Markus van der Giet
Joachim Hoyer
Stephen S. Furniss
John P. Foran
Adam Witkowski
Andrzej Januszewicz
Danny Schoors
Konstantinos Tsioufis
Benno J. Rensing
Manish Saxena
Benjamin Scott
G. André Ng
Stephan Achenbach
Roland E. Schmieder
Michael Schmid
Ajay Jain
Charles Knight
Anthony Mathur
Peter Balmforth
Sandra F. Luitjens
Gerard Smits
Dhanraj Mungur
Aleksander Prejbisz
Jacek Kadziela
Elżbieta Florczak
Joseph Galvin
Kyriakos Dimitriadis
Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
arteriovenous anastomosis
combined hypertension
isolated systolic hypertension
treatment resistant hypertension
title Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
title_full Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
title_fullStr Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
title_full_unstemmed Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
title_short Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension
title_sort effect of arteriovenous anastomosis on blood pressure reduction in patients with isolated systolic hypertension compared with combined hypertension
topic arteriovenous anastomosis
combined hypertension
isolated systolic hypertension
treatment resistant hypertension
url https://www.ahajournals.org/doi/10.1161/JAHA.116.004234
work_keys_str_mv AT christianott effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT melvindlobo effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT paulasobotka effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT felixmahfoud effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT alicestanton effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT johncockcroft effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT neilsulke effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT eamondolan effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT markusvandergiet effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT joachimhoyer effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT stephensfurniss effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT johnpforan effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT adamwitkowski effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT andrzejjanuszewicz effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT dannyschoors effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT konstantinostsioufis effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT bennojrensing effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT manishsaxena effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT benjaminscott effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT gandreng effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT stephanachenbach effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT rolandeschmieder effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT michaelschmid effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT ajayjain effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT charlesknight effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT anthonymathur effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT peterbalmforth effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT sandrafluitjens effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT gerardsmits effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT dhanrajmungur effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT aleksanderprejbisz effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT jacekkadziela effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT elzbietaflorczak effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT josephgalvin effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension
AT kyriakosdimitriadis effectofarteriovenousanastomosisonbloodpressurereductioninpatientswithisolatedsystolichypertensioncomparedwithcombinedhypertension